Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging

被引:114
作者
Eckert, T
Sailer, M
Kaufmann, J
Schrader, C
Peschel, T
Bodammer, N
Heinze, HJ
Schoenfeld, MA
机构
[1] Univ Magdeburg, Dept Neurol 2, D-39120 Magdeburg, Germany
[2] Hannover Med Sch, Dept Neurol & Clin Neurophysiol, D-30625 Hannover, Germany
关键词
multiple system atrophy; magnetization transfer imaging; Parkinson's disease;
D O I
10.1016/j.neuroimage.2003.08.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The differentiation of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) from idiopathic Parkinson's disease (IPD) is difficult. Magnetization transfer imaging (MTI), a measure that correlates with myelination and axonal density, was employed in this study in the attempt to distinguish between these disorders. Measurements were carried out in 15 patients with IPD, 12 patients with MSA, 10 patients with PSP, and in 20 aged-matched healthy control subjects. The main finding was a change in the magnetization transfer ratio in the globus pallidus, putamen, caudate nucleus, substantia nigra, and white matter in IPD, MSA, and PSP patients, matching the pathological features of the underlying disorder. Furthermore, stepwise linear discriminant analysis provided a good classification of the individual patients into the different disease groups. All IPD patients and control subjects were correctly separated from the MSA and PSP cohort, and all PSP patients and 11 of 12 MSA patients were correctly separated from the IPD and control cohort. There was also a fairly good discrimination of IPD patients from control subjects and of MSA from PSP patients. In conclusion, MTI revealed degenerative changes in patients with different parkinsonian syndromes matching the underlying pathological features of the different diseases, underlining the high potential of this method in distinguishing MSA and PSP from IPD. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 63 条
[11]   MULTICENTER STUDY OF PARKINSON MORTALITY WITH EARLY VERSUS LATER DOPA TREATMENT [J].
DIAMOND, SG ;
MARKHAM, CH ;
HOEHN, MM ;
MCDOWELL, FH ;
MUENTER, MD .
ANNALS OF NEUROLOGY, 1987, 22 (01) :8-12
[12]  
DOUSSET V, 1995, AM J NEURORADIOL, V16, P225
[13]   STRIATAL HYPOMETABOLISM DISTINGUISHES STRIATONIGRAL DEGENERATION FROM PARKINSONS-DISEASE [J].
EIDELBERG, D ;
TAKIKAWA, S ;
MOELLER, JR ;
DHAWAN, V ;
REDINGTON, K ;
CHALY, T ;
ROBESON, W ;
DAHL, JR ;
MARGOULEFF, D ;
FAZZINI, E ;
PRZEDBORSKI, S ;
FAHN, S .
ANNALS OF NEUROLOGY, 1993, 33 (05) :518-527
[14]   EARLY DIFFERENTIAL-DIAGNOSIS OF PARKINSONS-DISEASE WITH F-18 FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
EIDELBERG, D ;
MOELLER, JR ;
ISHIKAWA, T ;
DHAWAN, V ;
SPETSIERIS, P ;
CHALY, T ;
BELAKHLEF, A ;
MANDEL, F ;
PRZEDBORSKI, S ;
FAHN, S .
NEUROLOGY, 1995, 45 (11) :1995-2004
[15]  
Fahn S, 1987, Recent Dev. Park. Dis, P153
[16]   Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy [J].
Federico, F ;
Simone, IL ;
Lucivero, V ;
DeMari, M ;
Giannini, P ;
Iliceto, G ;
Mezzapesa, DM ;
Lamberti, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (03) :239-242
[17]   Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders [J].
Federico, F ;
Simone, IL ;
Lucivero, V ;
Iliceto, G ;
DeMari, M ;
Giannini, P ;
Mezzapesa, DM ;
Tarantino, A ;
Lamberti, P .
MOVEMENT DISORDERS, 1997, 12 (06) :903-909
[18]   Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis [J].
Filippi, M ;
Rocca, MA ;
Martino, G ;
Horsfield, MA ;
Comi, G .
ANNALS OF NEUROLOGY, 1998, 43 (06) :809-814
[19]   CORRELATION OF MAGNETIZATION-TRANSFER RATIO WITH CLINICAL DISABILITY IN MULTIPLE-SCLEROSIS [J].
GASS, A ;
BARKER, GJ ;
KIDD, D ;
THORPE, JW ;
MACMANUS, D ;
BRENNAN, A ;
TOFTS, PS ;
THOMPSON, AJ ;
MCDONALD, WI ;
MILLER, DH .
ANNALS OF NEUROLOGY, 1994, 36 (01) :62-67
[20]  
Ge YL, 2002, AM J NEURORADIOL, V23, P1334